Ceftazidime & Tazobactam For Inj. 281.25 Mg/562.5 Mg/1.125gm

What is Ceftazidime & Tazobactam for Injection?

Ceftazidime and Tazobactam for Injection is a combination antibiotic formulation containing ceftazidime, a third-generation cephalosporin antibiotic, and tazobactam, a beta-lactamase inhibitor. It is intended for use by qualified healthcare professionals for selected bacterial infections when supported by approved product information and clinical assessment. The listed strengths should be verified against the product specification.

Uses / Indications

This combination may be considered for certain bacterial infections caused by susceptible organisms, depending on the approved product information and applicable treatment guidelines. Potential clinical applications may include:

• Selected respiratory tract infections

• Certain urinary tract infections

• Skin and soft-tissue infections

• Other susceptible bacterial infections specified in the approved prescribing information

The precise approved indications depend on the specific formulation, local prescribing guidance, bacterial susceptibility and the patient’s clinical condition.

Benefits

• Combines ceftazidime with tazobactam in an injectable formulation.

• Ceftazidime interferes with bacterial cell-wall synthesis.

• Tazobactam inhibits certain beta-lactamase enzymes that can reduce the activity of some beta-lactam antibiotics.

• Provides listed strength options for healthcare-professional-directed treatment, subject to the approved product specification.

Side Effects

Common or Possible Side Effects

• Diarrhoea or loose stools

• Nausea or vomiting

• Skin rash or itching

• Injection-site discomfort

• Changes in liver-function test results

Serious Side Effects

• Severe allergic reactions, including swelling of the face or throat or difficulty breathing

• Severe or persistent diarrhoea

• Severe skin reactions

• Neurological effects such as confusion or seizures, particularly in susceptible patients or when dosing is inappropriate

Seek urgent medical care if serious symptoms occur. The exact adverse-effect profile should be confirmed against the approved product information for this combination.

How Does It Work?

Ceftazidime is a cephalosporin antibiotic that inhibits bacterial cell-wall synthesis by binding to relevant penicillin-binding proteins. Tazobactam inhibits certain beta-lactamase enzymes that can break down beta-lactam antibiotics. This may help protect susceptible antibiotics from enzymatic degradation. The combination’s effectiveness depends on the infecting organism, its susceptibility and the approved use of the specific formulation.

Dosage Guidelines

• The appropriate dose, frequency and treatment duration must be determined by a qualified healthcare professional.

• Dosing depends on the infection, its severity, the patient’s age and clinical condition, and kidney function.

• Preparation, compatibility and administration must follow the approved product information.

• Confirm the exact quantities of ceftazidime and tazobactam represented by each listed strength before use.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

This product may not be appropriate for patients who:

• Have a known serious allergy to ceftazidime, tazobactam, cephalosporins or relevant beta-lactam antibiotics.

• Have a history of severe hypersensitivity to related medicines, unless a qualified clinician determines that use is appropriate.

• Have another contraindication listed in the approved product information.

The patient’s allergy history and relevant medical conditions should be reviewed before treatment.

Drug / Product Interactions

Potential interactions or precautions may include:

• Medicines that may affect kidney function: additional assessment or monitoring may be needed.

• Other antibiotics: concurrent use should be guided by clinical need and product compatibility information.

• Anticoagulants or medicines affecting blood clotting: monitoring may be appropriate in selected patients.

• Other prescription medicines: the full medication list should be reviewed to assess potential interactions and patient-specific risks.

Safety Advice

• Use only under appropriate medical supervision.

• Inform the healthcare professional about previous antibiotic allergies and any kidney conditions.

• Report severe diarrhoea, confusion, seizures or signs of an allergic reaction promptly.

• Use antibiotics only for appropriate bacterial infections; they do not treat viral illnesses.

• Do not share the medicine or use leftover antibiotics without medical advice.

General Instructions

• The product should be prepared and administered by trained healthcare personnel.

• Follow the approved instructions for reconstitution, compatibility and administration.

• Inspect the vial and packaging before use; do not use damaged or questionable products.

• Do not use the product beyond its labelled expiry date.

• Follow the prescribed treatment plan and applicable infection-control procedures.

Special Dietary / Lifestyle Tips

• Follow the treating healthcare professional’s advice about diet and fluid intake.

• Maintain adequate hydration unless medically restricted.

• Seek medical advice if diarrhoea or vomiting becomes persistent or interferes with fluid intake.

• Do not alter the prescribed treatment plan without consulting the treating professional.

Comparison with Other Treatments

Ceftazidime and tazobactam combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Other antibiotics or antibiotic combinations may be selected according to the infection, suspected or confirmed bacteria, susceptibility results, allergy history and local treatment guidelines.

Different injectable antibiotics should not be considered interchangeable solely because they belong to similar therapeutic categories. Treatment selection should be made by a qualified healthcare professional.

Precautions & Warnings

• Allergy risk: Review previous reactions to cephalosporins, penicillins and other beta-lactam antibiotics.

• Kidney function: Assessment and dose adjustment may be required in some patients.

• Neurological effects: Patients with kidney impairment or other risk factors may require careful dosing and monitoring.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires prompt medical assessment.

• Pregnancy and breastfeeding: Use should be assessed by a healthcare professional according to the approved product information.

• Antimicrobial resistance: Use only when clinically indicated and in accordance with appropriate prescribing guidance.

Can I Use It With Other Medicines?

Ceftazidime and tazobactam may be used with other medicines when clinically indicated, but the combination should be reviewed by a qualified healthcare professional. Particular attention may be needed for medicines that affect kidney function and other products identified in the approved interaction information. Do not start, stop or change medicines without professional advice.

Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Frequently Asked Questions

1. What is Ceftazidime & Tazobactam for Injection used for?

It is a combination antibiotic formulation intended for selected bacterial infections caused by susceptible organisms, according to approved prescribing information.

2. What does tazobactam do in this combination?

Tazobactam inhibits certain beta-lactamase enzymes that can reduce the activity of some beta-lactam antibiotics.

3. What strengths are listed for this product?

The supplied strengths are 281.25 Mg, 562.5 Mg and 1.125gm. The individual component quantities should be confirmed against the approved product specification.

4. Can this injection treat viral infections?

No. Antibiotics treat susceptible bacterial infections and do not treat viral illnesses such as influenza or the common cold.

5. Who should administer this injection?

Qualified healthcare personnel should prepare and administer the product according to the approved instructions.

6. Can kidney function affect treatment?

Yes. Kidney function may influence dosing and monitoring, so the treating healthcare professional should be informed of any kidney condition.

7. How should the product be stored?

Follow the storage conditions specified in the approved product labelling and package insert.